These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34687104)

  • 1. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy.
    Grüter T; Motte J; Fisse AL; Bulut Y; Köse N; Athanasopoulos D; Otto S; Yoon MS; Schneider-Gold C; Gold R; Pitarokoili K
    Eur J Neurol; 2020 Dec; 27(12):2595-2603. PubMed ID: 32794258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.
    Härtig F; Ross M; Dammeier NM; Fedtke N; Heiling B; Axer H; Décard BF; Auffenberg E; Koch M; Rattay TW; Krumbholz M; Bornemann A; Lerche H; Winter N; Grimm A
    Neurotherapeutics; 2018 Apr; 15(2):439-451. PubMed ID: 29435815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes.
    Feng Y; Zhang Y; Su X; Zheng C; Lu Z
    Sci Rep; 2020 Oct; 10(1):16697. PubMed ID: 33028841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Attarian S; Franques J; Elisabeth J; Trébuchon A; Duclos Y; Wybrecht D; Verschueren A; Salort-Campana E; Pouget J
    Muscle Nerve; 2015 Apr; 51(4):541-8. PubMed ID: 25571892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
    J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
    Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative magnetic resonance neurography in chronic inflammatory demyelinating polyradiculoneuropathy: A longitudinal study over 6 years.
    Preisner F; Pitarokoili K; Lueling B; Motte J; Fisse AL; Grüter T; Godel T; Schwarz D; Heiland S; Gold R; Bendszus M; Kronlage M
    Ann Clin Transl Neurol; 2024 Mar; 11(3):593-606. PubMed ID: 38111964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy.
    Fisse AL; Pitarokoili K; Trampe N; Motte J; Kerasnoudis A; Gold R; Yoon MS
    J Neuroimaging; 2019 Mar; 29(2):223-232. PubMed ID: 30407676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
    De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
    Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative muscle ultrasound is useful for evaluating secondary axonal degeneration in chronic inflammatory demyelinating polyneuropathy.
    Hokkoku K; Matsukura K; Uchida Y; Kuwabara M; Furukawa Y; Tsukamoto H; Hatanaka Y; Sonoo M
    Brain Behav; 2017 Oct; 7(10):e00812. PubMed ID: 29075571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    J Neurol Sci; 2010 Oct; 297(1-2):11-4. PubMed ID: 20673919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution pattern of nerve enlargement in clinical subtypes of chronic inflammatory demyelinating polyneuropathy.
    Niu J; Zhang L; Hu N; Cui L; Liu M
    J Neuroimaging; 2024; 34(1):127-137. PubMed ID: 37823703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.